Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2026-02-22 @ 12:23 PM
Study NCT ID:
NCT01572792
Status:
COMPLETED
Last Update Posted:
2017-04-21
First Post:
2012-04-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04
Start Date Type:
None
Primary Completion Date:
2013-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-06
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-04
First Submit QC Date:
None
Study First Post Date:
2012-04-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-23
Results First Submit QC Date:
None
Results First Post Date:
2017-04-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-03-18
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-03-09
Last Update Post Date:
2017-04-21
Last Update Post Date Type:
ACTUAL